Literature DB >> 1899538

Intracameral tissue plasminogen activator for resolution of fibrin clots after glaucoma filtering procedures.

R C Tripathi, B J Tripathi, J K Park, L Quaranta, K Steinspair, E Lehman, J T Ernest.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1899538     DOI： 10.1016/s0002-9394(14)72272-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  5 in total

1.  Tissue plasminogen activator therapy for the eye.

Authors:  R C Tripathi; B J Tripathi
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

2.  Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.

Authors:  H Siatiri; A H Beheshtnezhad; H Asghari; N Siatiri; S Moghimi; N Piri
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

3.  193 nm excimer laser sclerostomy in pseudophakic patients with advanced open angle glaucoma.

Authors:  B D Allan; P P van Saarloos; R L Cooper; I J Constable
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

4.  Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis.

Authors:  Shunji Nakatake; Shigeo Yoshida; Shintaro Nakao; Ryoichi Arita; Miho Yasuda; Takeshi Kita; Hiroshi Enaida; Yuji Ohshima; Tatsuro Ishibashi
Journal:  BMC Ophthalmol       Date:  2014-04-26       Impact factor: 2.209

5.  Tissue Plasminogen Activator Effects on Fibrin Volume and the Ocular Proteome in a Juvenile Rabbit Model of Lensectomy.

Authors:  Jonathon B Young; Amanda Rae Buchberger; Joseph D Bogaard; Linda Berg Luecke; Matthew Runquist; Christine M B Skumatz; Iris S Kassem
Journal:  Transl Vis Sci Technol       Date:  2021-12-01       Impact factor: 3.283
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.